(2024)
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.
CANCER RESEARCH AND TREATMENT.
15,
5
(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
BREAST.
72,
(2023)
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
JOURNAL OF BREAST CANCER.
26,
6
(2023)
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
CANCERS.
15,
22
(2023)
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.
WORLD JOURNAL OF CLINICAL CASES.
11,
27
(2023)
Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.
JMIR PUBLIC HEALTH AND SURVEILLANCE.
9,
1
(2023)
Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
105,
1
(2023)
Breast Cancer Statistics in Korea, 2019.
JOURNAL OF BREAST CANCER.
26,
3
(2023)
Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population-Based Study by the SMARTSHIP Group.
CANCER RESEARCH AND TREATMENT.
55,
2
(2023)
Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level.
JOURNAL OF BREAST CANCER.
26,
2
(2023)
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.
CANCERS.
15,
5
(2023)
Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?.
ANNALS OF SURGICAL ONCOLOGY.
30,
2
(2023)
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY.
15,
(2022)
Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?.
ANNALS OF SURGICAL ONCOLOGY.
30,
2
(2022)
Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age >= 70 years: A hospital based-registry study.
BMC CANCER.
22,
1
(2022)
Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
CANCER RESEARCH AND TREATMENT.
(2022)
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.
JOURNAL OF BREAST CANCER.
25,
6
(2022)
Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.
CANCER RESEARCH AND TREATMENT.
(2022)
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?.
JOURNAL OF CLINICAL MEDICINE.
11,
21
Conference Paper
(2022)
Breast Cancer in Korea.
UNIVERSITY OF HAWAII( Women's Cancer Focus Group meeting).
UNITED STATES
(2019)
Epidermal growth factor receptor as therapeutic target in hormone receptor-positive breast cancer.
SABCS.
UNITED STATES
(2019)
Impact of chemotherapy and radiotherapy on tissue expander or implant removal in the patients who received mastectomy and immediate breast reconstruction.
SABCS.
UNITED STATES
(2019)
Risk of ipsilateral breast tumor recurrence in ductal carcinoma in situ following breast conserving surgery.
SABCS.
UNITED STATES
(2019)
The clinical significance of EGFR(+) and HER2(+) breast cancer and interaction with tumor associated macrophages.
SABCS.
UNITED STATES
(2019)
Low estrogen receptor positive (1-10%) breast cancer prevalence, treatment patterns and prognosis: A single institution’s experience in Korea.
SABCS.
UNITED STATES
(2019)
Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer.
SABCS.
UNITED STATES
(2019)
Radiologic complete response after neoadjuvant chemotherapy in advanced breast cancer can predict survival outcome, but not pathologic complete response.
SABCS.
UNITED STATES
(2019)
The 5-years conditional disease free survival and overall survival for breast cancer patients in Korea.
SABCS.
UNITED STATES
(2019)
Profiling protein-protein interactions at single-molecule level as a novel biomarker-driven screening method for the detection of tumor recurrence in breast cancer patients.
SABCS.
JAPAN
(2019)
Serum protein expression predicts neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
SABCS.
UNITED STATES
(2019)
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?.
유방암학회추계학술대회.
KOREA, REPUBLIC OF
(2019)
A MULTI-CENTER, OPEN-LABEL, PARALLEL, PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LUMINOMARKTM (INDOCYANINE GREEN 0.01MG +HYALURONIC ACID SODIUM 4MG/2ML) FOR CALIZATION IN PATIENTS.
GBCC.
KOREA, REPUBLIC OF
(2019)
A NEW DEVELOPED PREDICTED PROGNOSTIC SCORE
(GENESWELLTM BCT) AS A PREDICTOR OF RISK OF
RECURRENCE IN HR+/HER2- EARLY BREAST CANCER
IRRESPECTIVE OF AGE.
GBCC.
KOREA, REPUBLIC OF
(2019)
A PREDICTIVE MODEL FOR PATHOLOGIC COMPLETE RESPONSE IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY USING MACHINE LEARNING.
GBCC.
KOREA, REPUBLIC OF
(2019)
BASAL AND IL-1β-INDUCED IL-8 IS SUPPRESSED BY
CELASTROL IN TRIPLE NEGATIVE BREAST CANCER.
GBCC.
KOREA, REPUBLIC OF
(2019)
CCL2 DERIVED FROM EGFR AND HER2(+) BREAST CANCER CELLS RECRUITS TUMOR ASSOCIATED MACROPHAGES.
GBCC.
KOREA, REPUBLIC OF
(2019)
EFFECT OF POLOXAMER-BASED THERMO-SENSITIVE SOL-GEL ON SHOULDER MOTION AFTER AXILLARY LYMPH NODE DISSECTION IN PATIENTS WITH BREAST CANCER: A MULTI-CENTER DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIAL.
GBCC.
KOREA, REPUBLIC OF
(2016)
Impact of young age on recurrence and mortality after surgery in breast cancer:15 years active surveillance.
San Antonio Breast Cancer Symposium.
UNITED STATES
(2016)
Tamoxifen resistance:EGFR expression in hormone receptor-positive and HER2 negative breast cancer.
San Antonio Breast Cancer Symposium.
UNITED STATES